Course - Boston, MA, United States
Steven LaPlante, Ph.D., Founder & CEO, NMX Research & Solutions; Adjunct Professor, Institut National de la Recherche Scientifique (INRS)This dinner short course will reveal design strategies that led to drugs currently in the clinic and on the market. An emphasis will be made on the exploitation of the bioactive ligand conformations using combinations of NMR, X-ray, calculations and SAR. Rational design and the implications of other properties will be addressed which include atropisomer chirality, drug self-aggregation and ADMET. This course will be held prior to the start of CHI's 14th Annual Structure-Based Drug Design Conference.
Organization: Cambridge Healthtech Institute
Tue, May 20, 2014 - Tue, May 20, 2014
Westin Boston Waterfront
425 Summer Street, Boston, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.